lanreotide  - Drug Details
📊 Estimates lanreotide  Dialyzability By Different_Modalities

lanreotide 

Complete Drug Information

Drug Name
lanreotide 
Trade Names
Somatuline
Pregnancy Category
AU: C
Bioavailability
Approximately 80%
Routes of Administration
Intramuscular, subcutaneous
Protein Binding
78%%
Metabolism
In GI tract
Elimination
2 hours (immediate release)5 days (sustained release)
Excretion
Mostly bile duct
Formula
C54H69N11O10S2
Molar Mass
1096.33
Volume of Distribution
16.1 L/kg

🤰 Pregnancy Category Information

Category: AU: C

Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible.